Andrea A Zin1, Irena Tsui2, Julia Rossetto1,3, Zilton Vasconcelos1, Kristina Adachi4, Stephanie Valderramos5, Umme-Aiman Halai2, Marcos Vinicius da Silva Pone6, Sheila Moura Pone6, Joel Carlos Barros Silveira Filho7, Mitsue S Aibe6, Ana Carolina C da Costa1, Olivia A Zin8, Rubens Belfort3, Patricia Brasil9, Karin Nielsen-Saines4, Maria Elisabeth Lopes Moreira1. 1. Departamento de Pesquisa Clinica, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. 2. Department of Ophthalmology, University of California, Los Angeles. 3. Departamento de Oftalmologia, Federal University of São Paulo, São Paulo, Brazil. 4. Department of Medicine, Division of Infectious Diseases, University of California, Los Angeles. 5. Obstetrics, Gynecology, and Reproductive Sciences Department, University of California, San Francisco. 6. Departamento de Doenças Infecciosas, Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil. 7. Departamento de Oftalmologia, Universidade Unigranrio, Rio de Janeiro, Brazil. 8. Departamento de Oftalmologia, Hospital Federal dos Servidores do Estado, Rio de Janeiro, Brazil. 9. Laboratório de Doenças Febris Agudas, Instituto Nacional de Infectologia Evandro Chagas-Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
Abstract
Importance: Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero. Objective: To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy. Design, Setting, and Participants: In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil. Participants: Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus. Main Outcomes and Measures: Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection. Results: Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2). Conclusions and Relevance: Eye abnormalities may be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
Importance: Current guidelines recommend screening eye examinations for infants with microcephaly or laboratory-confirmed Zika virus infection but not for all infants potentially exposed to Zika virus in utero. Objective: To evaluate eye findings in a cohort of infants whose mothers had polymerase chain reaction-confirmed Zika virus infection during pregnancy. Design, Setting, and Participants: In this descriptive case series performed from January 2 through October 30, 2016, infants were examined from birth to 1 year of age by a multidisciplinary medical team, including a pediatric ophthalmologist, from Fernandes Figueira Institute, a Ministry of Health referral center for high-risk pregnancies and infectious diseases in children in Rio de Janeiro, Brazil. Participants: Mother-infant pairs from Rio de Janeiro, Brazil, who presented with suspected Zika virus infection during pregnancy were referred to our institution and had serum, urine, amniotic fluid, or placenta samples tested by real-time polymerase chain reaction for Zika virus. Main Outcomes and Measures: Description of eye findings, presence of microcephaly or other central nervous system abnormalities, and timing of infection in infants with confirmed Zika virus during pregnancy. Eye abnormalities were correlated with central nervous system findings, microcephaly, and the timing of maternal infection. Results: Of the 112 with polymerase chain reaction-confirmed Zika virus infection in maternal specimens, 24 infants (21.4%) examined had eye abnormalities (median age at first eye examination, 31 days; range, 0-305 days). Ten infants (41.7%) with eye abnormalities did not have microcephaly, and 8 (33.3%) did not have any central nervous system findings. Fourteen infants with eye abnormalities (58.3%) were born to women infected in the first trimester, 8 (33.3%) in the second trimester, and 2 (8.3%) in the third trimester. Optic nerve and retinal abnormalities were the most frequent findings. Eye abnormalities were statistically associated with microcephaly (odds ratio [OR], 19.1; 95% CI, 6.0-61.0), other central nervous system abnormalities (OR, 4.3; 95% CI, 1.6-11.2), arthrogryposis (OR, 29.0; 95% CI, 3.3-255.8), and maternal trimester of infection (first trimester OR, 5.1; 95% CI, 1.9-13.2; second trimester OR, 0.5; 95% CI, 0.2-1.2; and third trimester OR, 0.3; 95% CI, 0.1-1.2). Conclusions and Relevance: Eye abnormalities may be the only initial finding in congenital Zika virus infection. All infants with potential maternal Zika virus exposure at any time during pregnancy should undergo screening eye examinations regardless of the presence or absence of central nervous system abnormalities.
Authors: Anna Suy; Elena Sulleiro; Carlota Rodó; Élida Vázquez; Cristina Bocanegra; Israel Molina; Juliana Esperalba; María P Sánchez-Seco; Hector Boix; Tomás Pumarola; Elena Carreras Journal: N Engl J Med Date: 2016-12-07 Impact factor: 91.245
Authors: Vanessa van der Linden; André Pessoa; William Dobyns; A James Barkovich; Hélio van der Linden Júnior; Epitacio Leite Rolim Filho; Erlane Marques Ribeiro; Mariana de Carvalho Leal; Pablo Picasso de Araújo Coimbra; Maria de Fátima Viana Vasco Aragão; Islane Verçosa; Camila Ventura; Regina Coeli Ramos; Danielle Di Cavalcanti Sousa Cruz; Marli Tenório Cordeiro; Vivian Maria Ribeiro Mota; Mary Dott; Christina Hillard; Cynthia A Moore Journal: MMWR Morb Mortal Wkly Rep Date: 2016-12-02 Impact factor: 17.586
Authors: Patrícia Brasil; José P Pereira; M Elisabeth Moreira; Rita M Ribeiro Nogueira; Luana Damasceno; Mayumi Wakimoto; Renata S Rabello; Stephanie G Valderramos; Umme-Aiman Halai; Tania S Salles; Andrea A Zin; Dafne Horovitz; Pedro Daltro; Marcia Boechat; Claudia Raja Gabaglia; Patrícia Carvalho de Sequeira; José H Pilotto; Raquel Medialdea-Carrera; Denise Cotrim da Cunha; Liege M Abreu de Carvalho; Marcos Pone; André Machado Siqueira; Guilherme A Calvet; Ana E Rodrigues Baião; Elizabeth S Neves; Paulo R Nassar de Carvalho; Renata H Hasue; Peter B Marschik; Christa Einspieler; Carla Janzen; James D Cherry; Ana M Bispo de Filippis; Karin Nielsen-Saines Journal: N Engl J Med Date: 2016-03-04 Impact factor: 91.245
Authors: Rita W Driggers; Cheng-Ying Ho; Essi M Korhonen; Suvi Kuivanen; Anne J Jääskeläinen; Teemu Smura; Avi Rosenberg; D Ashley Hill; Roberta L DeBiasi; Gilbert Vezina; Julia Timofeev; Fausto J Rodriguez; Lev Levanov; Jennifer Razak; Preetha Iyengar; Andrew Hennenfent; Richard Kennedy; Robert Lanciotti; Adre du Plessis; Olli Vapalahti Journal: N Engl J Med Date: 2016-03-30 Impact factor: 91.245
Authors: Bruno de Paula Freitas; João Rafael de Oliveira Dias; Juliana Prazeres; Gielson Almeida Sacramento; Albert Icksang Ko; Maurício Maia; Rubens Belfort Journal: JAMA Ophthalmol Date: 2016-05-01 Impact factor: 7.389
Authors: Christie L Walker; Audrey A Merriam; Eric O Ohuma; Manjiri K Dighe; Michael Gale; Lakshmi Rajagopal; Aris T Papageorghiou; Cynthia Gyamfi-Bannerman; Kristina M Adams Waldorf Journal: Am J Obstet Gynecol Date: 2018-05-05 Impact factor: 8.661
Authors: Irena Tsui; Luiza M Neves; Kristina Adachi; Stephanie L Gaw; Jose Paulo Pereira; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira; Andrea A Zin Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2019-12-01 Impact factor: 1.300
Authors: Cheryl S Broussard; Carrie K Shapiro-Mendoza; Georgina Peacock; Sonja A Rasmussen; Cara T Mai; Emily E Petersen; Romeo R Galang; Kimberly Newsome; Megan R Reynolds; Suzanne M Gilboa; Coleen A Boyle; Cynthia A Moore Journal: Pediatrics Date: 2018-02 Impact factor: 7.124
Authors: Andrea A Zin; Irena Tsui; Julia D Rossetto; Stephanie L Gaw; Luiza M Neves; Olivia A Zin; Lorena Haefeli; Joel Carlos Barros Silveira Filho; Kristina Adachi; Marcos Vinicius da Silva Pone; Sheila Moura Pone; Natalia Molleri; Jose Paulo Pereira; Rubens Belfort; Vaithilingaraja Arumugaswami; Zilton Vasconcelos; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: J AAPOS Date: 2018-10-22 Impact factor: 1.220
Authors: Virginia Vilar Sampaio; Adriana S O Melo; Anne L Coleman; Fei Yu; Sarah Rogeria Martins; Luciana Portela Rabello; Jousilene Sales Tavares; Karin Nielsen-Saines Journal: J Pediatric Infect Dis Soc Date: 2021-08-14 Impact factor: 3.164